Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of PacliALL in Metastatic Breast Cancer
NCT02136927Phase 1Terminated
- Sponsor
- Sun Pharma
- Start
- Aug 2014
- Primary completion
- Apr 2016
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nab-paclitaxel in breast cancer, sponsored by Sun Pharma. Primary endpoint: Maximum observed concentration. Started Aug 2014; status: terminated.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02136927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02136927.